A Randomised, Controlled, Assessor-blind, Parallel Groups, Multicentre Trial in India Comparing the Efficacy and Safety of FE 999049 (Follitropin Delta) With Follitropin Alfa (GONAL-F) in Controlled Ovarian Stimulation in Women Undergoing an Assisted Reproductive Technology Programme
Latest Information Update: 07 Feb 2024
At a glance
- Drugs Follitropin alfa (Primary) ; Follitropin delta (Primary)
- Indications Female infertility
- Focus Registrational; Therapeutic Use
- Acronyms IRIS
- Sponsors Ferring Pharmaceuticals
- 01 Feb 2024 Status changed from active, no longer recruiting to completed.
- 27 Nov 2023 Planned End Date changed from 1 Feb 2024 to 21 Dec 2023.
- 27 Nov 2023 Planned primary completion date changed from 1 Feb 2024 to 21 Dec 2023.